IMPROVED VIRUS SAFETY AND PURITY OF A CHROMATOGRAPHICALLY PRODUCED FACTOR-IX CONCENTRATE BY NANOFILTRATION

被引：31
|
作者：
HOFFER, L
SCHWINN, H
BIESERT, L
JOSIC, D
机构：
[1] OCTAPHARMA PHARMAZEUT PROD MBH,A-1100 VIENNA,AUSTRIA
[2] GEORG SPEYER HAUS,D-60596 FRANKFURT,GERMANY
来源：
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1995年 / 669卷 / 02期
关键词：
D O I：
10.1016/0378-4347(95)00107-T
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
A virus removal system based on tangential flow filtration was introduced into a Factor IX production process. Beside the intended virus reduction potency of filter membranes, an additional purification effect could be achieved. This purification effect was evaluated in detail by means of sodium dodecyl sulphate-polyacrylamide gel electrophoresis and size-exclusion HPLC. High-molecular-mass impurities were retained by the membrane, thus increasing the specific activity of the product.
引用
收藏
页码：187 / 196
页数：10
相关论文
共 50 条
  • [1] VIRUS SAFETY OF PASTEURIZED FACTOR-IX CONCENTRATE - A MULTICENTRIC STUDY
    AUERSWALD, G
    MITTLER, U
    POPP, M
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 455 - 455
  • [2] TOWARDS A FACTOR-IX CONCENTRATE OF HIGH-PURITY
    DENIS, SW
    KOENDERMAN, AHL
    HIEMSTRA, H
    OVER, J
    TRANSFUSION, 1991, 31 (04) : 376 - 376
  • [3] A COAGULATION FACTOR-IX CONCENTRATE OF HIGH-PURITY
    KOENDERMAN, AHL
    VANDUREN, N
    MULLER, EJ
    BRANDS, L
    TERHART, HGJ
    HAKKENNES, CT
    KLEYN, GTOV
    HIEMSTRA, H
    OVER, J
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1161 - 1161
  • [4] COMPARISON OF THE RECOVERY AND HALF-LIFE OF A HIGH-PURITY FACTOR-IX CONCENTRATE WITH THOSE OF A FACTOR-IX COMPLEX CONCENTRATE
    POON, MC
    ALEDORT, LM
    ANDERLE, K
    KUNSCHAK, M
    MORFINI, M
    TRANSFUSION, 1995, 35 (04) : 319 - 323
  • [5] HIGH RECOVERY OF FACTOR-IX CONCENTRATE OF HIGH-PURITY
    BRODNIEWICZPROBA, T
    LAVOIE, L
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 60 - 60
  • [6] MONOCOMPONENT FACTOR-IX - A HIGH-PURITY FACTOR-IX CONCENTRATE FOR THE TREATMENT OF PATIENTS WITH HEMOPHILIA-B
    OATES, A
    HUGHES, E
    KUPCZYK, G
    MACGREGOR, A
    HERRINGTON, R
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1284 - 1284
  • [7] VIROLOGICAL SAFETY OF THE PURIFIED FACTOR-IX CONCENTRATE, REPLENINE
    ROBERTS, P
    HAEMOPHILIA, 1995, 1 : 19 - 22
  • [8] PRECLINICAL EVALUATION OF THROMBOGENICITY OF A HIGH-PURITY FACTOR-IX CONCENTRATE
    FELDMAN, PA
    MACGREGOR, IR
    FERGUSON, JM
    MCLAUGHLIN, LF
    SIMS, GE
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1281 - 1281
  • [9] COMPARISON OF PHARMACOKINETICS OF FACTOR-IX CONCENTRATE AND FACTOR-IX COMPLEX PREPARATIONS
    POON, MC
    FRITSCH, S
    KUNSCHAK, M
    MORFINI, M
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1020 - 1020
  • [10] COAGULATION FACTOR-IX - SUCCESSFUL SURGICAL EXPERIENCE WITH A PURIFIED FACTOR-IX CONCENTRATE
    GOLDSMITH, JC
    KASPER, CK
    BLATT, PM
    GOMPERTS, ED
    KESSLER, CM
    THOMPSON, AR
    HERRING, SW
    NOVAK, PL
    AMERICAN JOURNAL OF HEMATOLOGY, 1992, 40 (03) : 210 - 215
12345